JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2025
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals held its 49th Annual General Meeting on August 6, 2025, at 1:30 PM via video conference, with 54 members present. Chairman Mr. Arun Duggal chaired the meeting, while CEO Mr. Nikhil Chopra briefed members on the company's FY2024-25 performance and CFO Mr. Narayan Saraf answered shareholder queries. Members were presented with 9 ordinary resolutions and 5 special resolutions (14 items in total) for approval through remote e-voting and e-voting at the meeting. The statutory auditors' report and secretarial audit report were both clean, with no qualifications, observations, or comments. Voting results are expected to be declared on or before August 8, 2025, and the meeting concluded at 2:45 PM.
This is a routine procedural filing confirming the AGM was conducted smoothly with clean audit reports, which is mildly positive for shareholder confidence. The actual market impact will depend on the voting results for the 14 resolutions and any new disclosures that emerge, due by August 8, 2025.